Abstract

Kayexalate in Lactulose

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2021 - Volume 25, Number 6

Page(s): 501

Download in electronic PDF format for $75
  • Kayexalate in Lactulose Page 1

Abstract

A formulation for preparing Kayexalate in Lactulose. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • kayexalate
  • lactulose
  • oral suspension
  • formulation
  • hyperkalemia
  • potassium
  • osmotic stool softener

Related Categories

  • FORMULATIONS
  • GASTROENTEROLOGY
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2021
Pg. 501
Kayexalate in Lactulose
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 10-14
Women's Oral Health: Is There a Hormonal Link?
Author(s): Preckshot John
Jan/Feb 2014
Pg. 67
Potassium Chloride 2-mEq/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 323-324
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions
Author(s): Quay Irene, Tan Edward
Sep/Oct 2003
Pg. 389-393
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Author(s): Alexander Kenneth S, Thyangarajapuram N
Sep/Oct 2023
Pg. 420
Nitazoxanide 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2016
Pg. 438-439
A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution
Author(s): Tannous Elias, Tal Yana, Amarny Kamal
Mar/Apr 2017
Pg. 160-163
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Author(s): Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
Jan/Feb 2001
Pg. 9-12
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Author(s): Schotik Debora
Jan/Feb 2003
Pg. 61
Potassium Iodide 130-mg Capsules and Potassium Iodide 16-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2023
Pg. 58-59
Suspension Solution, Sugar Free
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 326
Losartan Potassium 2.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 248
Losartan Potassium 2.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2003
Pg. 233-239
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Author(s): Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
Mar/Apr 2017
Pg. 105-108
Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students
Author(s): Benischek Rita
Sep/Oct 2021
Pg. 420
Sorafenib 20-mg/mL in Oil Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 321
Atomoxetine 4-mg/mL Oral Solution/Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 415
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 416
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 505
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr